MedPath

Meiziya Kang LVR16 Capsules

Registration Number: MAL22046086TC

Approved
Approval ID

4be4cc4e0db66e3d

Registration Number

MAL22046086TC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (3)

Silybum marianumActive
Monograph: silybum marianum
Taraxacum mongolicumActive
Monograph: taraxacum mongolicum
Lycium barbarumActive
Monograph: lycium barbarum

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Meiziya Kang LVR16 Capsules - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform